Literature DB >> 20593051

Portal hypertensive enteropathy before and after variceal obliteration: an endoscopic, histopathologic and immunohistochemical study.

Hisham R El-Khayat1, Ahmed El Khattib, Mona Nosseir, Mohamed Aboul Ezz, Hussein El-Amin, Yasser M Fouad.   

Abstract

AIM: To study portal hypertensive enteropathy (PHE) before and after the obliteration of esophageal varices.
METHODS: 30 patients with portal hypertension and esophageal varices were included. Band ligation was performed for every patient until the obliteration of esophageal varices. Enteroscopy and biopsies from gastric, duodenal and jejunal mucosa were taken at the beginning of the study and after variceal obliteration. Morphometric measurement of mean vascular areas and estimation of tissue vascular endothelial growth factor (VEGF) were also completed.
RESULTS: The number of patients with enteropathy increased from 6.6% before obliteration to 46.7% after variceal obliteration (p< 0.001). Angiogenesis, vascular ectasia and blood extravasation were the main histopathological findings and all increased significantly after variceal obliteration. The mean vascular area of ectatic vessels in the gastric, duodenal and jejunal biopsies also increased after variceal obliteration. The mean VEGF in the gastric, duodenal and jejunal biopsies increased after variceal obliteration. The mean corpuscular volume (MCV) and hemoglobin (Hb) concentration were significantly lower after variceal obliteration.
CONCLUSION: the portal hypertensive enteropathic changes increased in frequency and severity after esophageal variceal obliteration with a probability of causing anemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593051

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  8 in total

Review 1.  Portal hypertensive enteropathy.

Authors:  Parit Mekaroonkamol; Robert Cohen; Saurabh Chawla
Journal:  World J Hepatol       Date:  2015-02-27

2.  Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.

Authors:  Astrit R Hamza; Avdyl S Krasniqi; Pramod Kadaba Srinivasan; Mamdouh Afify; Christian Bleilevens; Uwe Klinge; René H Tolba
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study.

Authors:  Reda Elwakil; Ashraf Mohammad Al Breedy; Hoda Hassan Abou Gabal
Journal:  Hepatol Int       Date:  2016-03-01       Impact factor: 6.047

4.  The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue.

Authors:  Alexandra Lind; Peter D Siersema; Johannes G Kusters; Jan A M Van der Linden; Edward F Knol; Leo Koenderman
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

5.  Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation.

Authors:  Kawano Seiji; Takaki Akinobu; Iwamuro Masaya; Yasunaka Tetsuya; Kono Yoshiyasu; Miura Kou; Inokuchi Toshihiro; Kawahara Yoshiro; Umeda Yuzo; Yagi Takahito; Okada Hiroyuki
Journal:  Biomed Res Int       Date:  2017-01-11       Impact factor: 3.411

6.  Gastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver Cirrhosis.

Authors:  Rohini Krishna; Samuel O Igbinedion; Richie Diaz; Nazneen Hussain; Moheb Boktor
Journal:  Case Rep Gastrointest Med       Date:  2018-10-18

7.  Portal hypertensive duodenopathy manifesting as "kissing" duodenal ulcers in a nigerian with alcoholic cirrhosis: a case report and brief review of the literature.

Authors:  Aderemi Oluyemi; Adeniyi Amole
Journal:  Case Rep Med       Date:  2012-10-21

Review 8.  Capsule Endoscopy for Portal Hypertensive Enteropathy.

Authors:  Seong Ran Jeon; Jin-Oh Kim
Journal:  Gastroenterol Res Pract       Date:  2015-12-27       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.